Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Phoenix location
Access macular degeneration specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
Check if you qualify for this macular degeneration clinical trial in Phoenix, AZ
No-Cost Study Care
Local to Phoenix
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.
Sponsor: Hoffmann-La Roche
Yes, this clinical trial (NCT03683251) has an active research site in Phoenix, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for macular degeneration treatment options in Phoenix, AZ, this clinical trial (NCT03683251) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all macular degeneration clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Phoenix — not just this study.
Browse Rheumatoid Arthritis Trials in Phoenix →